Carbapenem Resistance in Acinetobacter calcoaceticus-baumannii Complex Isolates From Kathmandu Model Hospital, Nepal, Is Attributed to the Presence of blaOXA-23-like and blaNDM-1 Genes.

The Acinetobacter calcoaceticus-baumannii (ACB) complex, also known as ACB complex, consists of four bacterial species that can cause opportunistic infections in humans, especially in hospital settings. Conventional therapies for susceptible strains of the ACB complex include broad‐spectrum cephalos...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2024; pp. 1 - 14
Autores principales: Gurung, Anupama, Napit, Rajindra, Shrestha, Basudha, Lekhak, Binod, Mohammadi, Saeed
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell 8/12/2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179674145&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 179674145
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 8/12/2024
      vid: 2024
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        179674145
        179674145
        179674145
        10.1155/2024/8842625
        179674145
      ppf: 1
      ppct: 13
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Carbapenem Resistance in Acinetobacter calcoaceticus-baumannii Complex Isolates From Kathmandu Model Hospital, Nepal, Is Attributed to the Presence of blaOXA-23-like and blaNDM-1 Genes.
      aug:
        au:
          Gurung, Anupama
          Napit, Rajindra
          Shrestha, Basudha
          Lekhak, Binod
          Mohammadi, Saeed
        affil: Central Department of Microbiology,, Tribhuvan University,, Kirtipur, Nepal, tribhuvan-university.edu.np
      sug:
        subj:
          Acinetobacter Infections Epidemiology
          Drug Resistance, Microbial
          Acinetobacter Infections Familial and Genetic
          Acinetobacter Infections Drug Therapy
          Carbapenems Adverse Effects
          Human
          Nepal
          Prospective Studies
          Cross Sectional Studies
          Microbial Culture and Sensitivity Tests
          Molecular Diagnostic Techniques
          Polymerase Chain Reaction
          Data Analysis Software
          Chi Square Test
          Funding Source
      ab: The Acinetobacter calcoaceticus-baumannii (ACB) complex, also known as ACB complex, consists of four bacterial species that can cause opportunistic infections in humans, especially in hospital settings. Conventional therapies for susceptible strains of the ACB complex include broad‐spectrum cephalosporins, β‐lactam/β‐lactamase inhibitors, and carbapenems. Unfortunately, the effectiveness of these antibiotics has declined due to increasing rates of resistance. The predominant resistance mechanisms identified in the ACB complex involve carbapenem‐resistant (CR) oxacillinases and metallo‐β‐lactamases (MBLs). This research, conducted at Kathmandu Model Hospital in Nepal, sought to identify genes associated with CR, specifically blaNDM‐1, blaOXA‐23‐like, and blaOXA‐24‐like genes in carbapenem‐resistant Acinetobacter calcoaceticus-baumannii (CR‐ACB) complex. Additionally, the study is aimed at identifying the ACB complex through the sequencing of the 16s rRNA gene. Among the 992 samples collected from hospitalized patients, 43 (approximately 4.334%) tested positive for the ACB complex. These positive samples were mainly obtained from different hospital units, including intensive care units (ICUs); cabins; and neonatal, general, and maternity wards. The prevalence of infection was higher among males (58.14%) than females (41.86%), with the 40–50 age group showing the highest infection rate. In susceptibility testing, colistin and polymyxin B exhibited a susceptibility rate of 100%, whereas all samples showed resistance to third‐generation cephalosporins. After polymyxins, gentamicin (30.23%) and amikacin (34.88%) demonstrated the highest susceptibility. A substantial majority (81.45%) of ACB complex isolates displayed resistance to carbapenems, with respiratory and pus specimens being the primary sources. Polymerase chain reaction (PCR) revealed that the primary CR gene within the ACB complex at this hospital was blaOXA-23-like, followed by blaNDM-1. To ensure the accuracy of the phenotypic assessment, 12 samples were chosen for 16s rRNA sequencing using Illumina MiSeq™ to confirm that they are Acinetobacter species. QIIME 2.0 analysis confirmed all 12 isolates to be Acinetobacter species. In the hospital setting, a substantial portion of the ACB complex carries CR genes, rendering carbapenem ineffective for treatment.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N